“Pharma Wholesale and Distribution market set to grow to $1,447bn by 2025” says new Visiongain report
01 October 2019
Visiongain has launched a new pharma report: Pharma Wholesale Market Forecasts 2020-2030: Branded Drugs, Generic Drugs, US, China, Japan, Germany, France, Brazil, Italy, Spain, UK, India, Russia, RoW.
The pharmaceutical wholesale and distribution market is influenced by the play of a variety of factors; it has both strengths and weaknesses and faces both opportunities and threats. The market will be driven by an overall increased demand for pharmaceuticals owing to the growing ageing population of developed countries and the increasing access to healthcare of the expanding middle class in the emerging economies.
The lead analyst of the report commented "Over the course of the forecast period, all national pharmaceutical wholesale and distribution markets discussed in this report will experience growth. However, this growth will be significantly faster in emerging markets, such as China. Growth will be faster in these emerging markets as it mirrors growth in the pharmaceutical markets; demand for prescription pharmaceuticals will become much higher in developing countries."
Leading companies featured in the report include Alfresa Holdings, AmerisourceBergen, Cardinal Health, McKesson, Medipal, PHOENIX Group, Shanghai Pharma, SINOPHARM, Suzuken, Walgreens Boots Alliance and other companies.
Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongain.com or call her on +44 (0) 207 336 6100.
About Visiongain
Visiongain is one of the fastest growing and most innovative independent media companies in Europe. Based in London, UK, Visiongain produces a host of business-to-business reports focusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.
Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.
Recent News
Visiongain Publishes Automation in Biopharma Industry Market Report 2023-2033
The global Automation in Biopharma Industry market was valued at US$1,784.1 million in 2022 and is projected to grow at a CAGR of 5.7% during the forecast period 2023-2033.
20 March 2023
Read
Visiongain Publishes eClinical Solutions Market Report 2023-2033
The global eClinical Solutions market was valued at US$8.03 billion in 2022 and is projected to grow at a CAGR of 13.09% during the forecast period 2023-2033.
17 March 2023
Read
Visiongain Publishes Therapeutic Respiratory Devices Market Report 2023-2033
The global Therapeutic Respiratory Devices market was valued at US$59.49 billion in 2022 and is projected to grow at a CAGR of 8.02% during the forecast period 2023-2033.
15 March 2023
Read
Visiongain Publishes Regenerative Medicine Market Report 2023-2033
The global Regenerative Medicine market was valued at US$ 50.37 billion in 2022 and is projected to grow at a CAGR of 18.40% during the forecast period 2023-2033.